Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 2:53 pm Sale | 13G | Assertio Therapeutics Inc ASRT | Allianz Global Investors U.S. Holdings LLC | 0 0.000% | -5,911,875 (Position Closed) | View |
| 2020-03-26 4:26 pm Purchase | 13D | Zyla Life Sciences ZCOR | Assertio Therapeutics Inc ASRT | 4,854,863 51.000% | 4,854,863 (New Position) | View |
| 2020-02-14 4:26 pm Purchase | 13G | Assertio Therapeutics Inc ASRT | D. E. SHAW & CO L.P. | 4,506,585 5.600% | 447,169 (+11.02%) | View |
| 2020-02-14 11:14 am Sale | 13G | Assertio Therapeutics Inc ASRT | ARMISTICE CAPITAL LLC | 0 0.000% | -3,278,000 (Position Closed) | View |
| 2020-02-13 1:28 pm Purchase | 13G | Assertio Therapeutics Inc ASRT | Allianz Global Investors U.S. Holdings LLC | 5,911,875 7.300% | 5,911,875 (New Position) | View |
| 2020-02-12 8:05 pm Purchase | 13G | Assertio Therapeutics Inc ASRT | RENAISSANCE TECHNOLOGIES LLC | 6,529,527 8.090% | 1,860,936 (+39.86%) | View |
| 2020-02-12 11:13 am Sale | 13G | Assertio Therapeutics Inc ASRT | VANGUARD GROUP INC | 5,152,682 6.380% | -1,269,912 (-19.77%) | View |
| 2020-02-12 10:26 am Sale | 13G | Assertio Therapeutics Inc ASRT | DIMENSIONAL FUND ADVISORS LP | 3,919,354 4.860% | -29,160 (-0.74%) | View |
| 2020-01-10 2:51 pm Sale | 13G | Assertio Therapeutics Inc ASRT | BlackRock Inc. BLK | 5,797,457 7.200% | -4,603,085 (-44.26%) | View |
| 2019-11-12 4:02 pm Purchase | 13G | Assertio Therapeutics Inc ASRT | D. E. SHAW & CO L.P. | 4,059,416 5.000% | 4,059,416 (New Position) | View |